BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7780073)

  • 1. Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients.
    Spiess BD; Gillies BS; Chandler W; Verrier E
    J Cardiothorac Vasc Anesth; 1995 Apr; 9(2):168-73. PubMed ID: 7780073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboelastography-based transfusion algorithm reduces blood product use after elective CABG: a prospective randomized study.
    Ak K; Isbir CS; Tetik S; Atalan N; Tekeli A; Aljodi M; Civelek A; Arsan S
    J Card Surg; 2009; 24(4):404-10. PubMed ID: 19583608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for hemorrhage-related reexploration and blood transfusion after conventional versus coronary revascularization without cardiopulmonary bypass.
    Frankel TL; Stamou SC; Lowery RC; Kapetanakis EI; Hill PC; Haile E; Corso PJ
    Eur J Cardiothorac Surg; 2005 Mar; 27(3):494-500. PubMed ID: 15740962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cardiac surgery program at the Royal Columbian Hospital: review of the first fiscal year.
    Fedoruk LM; Stewart KM; Hayden RI
    Can J Surg; 1993 Dec; 36(6):541-5. PubMed ID: 8258135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of clopidogrel premedication in off-pump cardiac surgery: are we forfeiting the benefits of reduced hemorrhagic sequelae?
    Kapetanakis EI; Medlam DA; Petro KR; Haile E; Hill PC; Dullum MK; Bafi AS; Boyce SW; Corso PJ
    Circulation; 2006 Apr; 113(13):1667-74. PubMed ID: 16567570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of acute autologous blood transfusion on coagulation dysfunction after cardiopulmonary bypass.
    Zisman E; Eden A; Shenderey A; Meyer G; Balagula M; Ammar R; Pizov R
    Eur J Anaesthesiol; 2009 Oct; 26(10):868-73. PubMed ID: 19528806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Living without aprotinin: the results of a 5-year blood saving program in cardiac surgery.
    Ranucci M; Castelvecchio S; Romitti F; Isgrò G; Ballotta A; Conti D
    Acta Anaesthesiol Scand; 2009 May; 53(5):573-80. PubMed ID: 19173686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resource utilization in on- and off-pump coronary artery surgery: factors influencing postoperative length of stay--an experience of 1,746 consecutive patients undergoing fast-track cardiac anesthesia.
    Scott BH; Seifert FC; Grimson R; Glass PS
    J Cardiothorac Vasc Anesth; 2005 Feb; 19(1):26-31. PubMed ID: 15747265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on- versus off-cardiopulmonary bypass: a randomised trial.
    Niranjan G; Asimakopoulos G; Karagounis A; Cockerill G; Thompson M; Chandrasekaran V
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):271-7. PubMed ID: 16829083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of transfusion requirements for cardiac surgical procedures at a blood conservation center.
    Moskowitz DM; Klein JJ; Shander A; Cousineau KM; Goldweit RS; Bodian C; Perelman SI; Kang H; Fink DA; Rothman HC; Ergin MA
    Ann Thorac Surg; 2004 Feb; 77(2):626-34. PubMed ID: 14759450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of preoperative clopidogrel on bleeding after coronary artery bypass surgery.
    Kang W; Theman TE; Reed JF; Stoltzfus J; Weger N
    J Surg Educ; 2007; 64(2):88-92. PubMed ID: 17462208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboelastography is a suboptimal test for determination of the underlying cause of bleeding associated with cardiopulmonary bypass and may not predict a hypercoagulable state.
    Welsh KJ; Padilla A; Dasgupta A; Nguyen AN; Wahed A
    Am J Clin Pathol; 2014 Oct; 142(4):492-7. PubMed ID: 25239416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery.
    Cui Y; Hei F; Long C; Feng Z; Zhao J; Yan F; Wang Y; Liu J
    Artif Organs; 2010 Nov; 34(11):955-60. PubMed ID: 21092037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reexploration for bleeding after coronary artery bypass surgery: risk factors, outcomes, and the effect of time delay.
    Karthik S; Grayson AD; McCarron EE; Pullan DM; Desmond MJ
    Ann Thorac Surg; 2004 Aug; 78(2):527-34; discussion 534. PubMed ID: 15276512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Open heart operations without transfusion using a multimodality blood conservation strategy in 50 Jehovah's Witness patients: implications for a "bloodless" surgical technique.
    Rosengart TK; Helm RE; DeBois WJ; Garcia N; Krieger KH; Isom OW
    J Am Coll Surg; 1997 Jun; 184(6):618-29. PubMed ID: 9179119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Off-pump coronary artery bypass grafting provides complete revascularization with reduced myocardial injury, transfusion requirements, and length of stay: a prospective randomized comparison of two hundred unselected patients undergoing off-pump versus conventional coronary artery bypass grafting.
    Puskas JD; Williams WH; Duke PG; Staples JR; Glas KE; Marshall JJ; Leimbach M; Huber P; Garas S; Sammons BH; McCall SA; Petersen RJ; Bailey DE; Chu H; Mahoney EM; Weintraub WS; Guyton RA
    J Thorac Cardiovasc Surg; 2003 Apr; 125(4):797-808. PubMed ID: 12698142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute kidney injury after cardiac surgery: focus on modifiable risk factors.
    Karkouti K; Wijeysundera DN; Yau TM; Callum JL; Cheng DC; Crowther M; Dupuis JY; Fremes SE; Kent B; Laflamme C; Lamy A; Legare JF; Mazer CD; McCluskey SA; Rubens FD; Sawchuk C; Beattie WS
    Circulation; 2009 Feb; 119(4):495-502. PubMed ID: 19153273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute plateletpheresis and aprotinin reduces the need for blood transfusion following Ross operation.
    Al-Rashidi F; Bhat M; Pierre L; Koul B
    Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):618-22. PubMed ID: 17670731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.